The National Medical Insurance Administration and other two departments: support innovative drugs to enter the basic medical insurance drug catalogue and the commercial health insurance innovative drug catalogue
2025-07-01 01:36:40
On July 1st, the National Medical Insurance Administration and other two departments issued the "Several Measures to Support the High-Quality Development of Innovative Drugs", which proposed to improve the dynamic adjustment mechanism of the basic medical insurance drug catalogue. Based on the affordability of the medical insurance fund, the basic medical needs of the masses, and the progress of clinical technology, regularly adjust and optimize the basic medical insurance drug catalogue. On the basis of adhering to the "basic insurance", eligible innovative drugs will be included in the medical insurance catalogue according to procedures. Innovative drugs necessary to deal with special circumstances such as major public health events can be studied in consultation with relevant departments to temporarily include them in the scope of medical insurance payment.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
